Compugen Stock

Compugen FCF/Debt

The Free Cash Flow to Debt Ratio of Compugen (CGEN) as of Sep 4, 2026 is 150.28 %. In the previous year, Free Cash Flow to Debt Ratio was 257.50 % — a change of -41.64% (lower).

FCF/Debt

150.28 %

YoY

-41.64%

Last updated:

Free Cash Flow to Debt Ratio of Compugen is 2026 150.28 % . Free Cash Flow to Debt Ratio of Compugen was 2025 257.50 % . It decreases by -41.64% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Free Cash Flow to Debt Ratio of Compugen is 150.28 % in 2026.

Free Cash Flow to Debt Ratio of Compugen changed from 257.50 % to 150.28 %, representing a -41.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Compugen

All Key Metrics — Compugen